Gold Co. 'Is in Good Shape Financially' Despite Shortfall

Research Report
  ()
The company aims to achieve record production in Q4/22 to recover from the hit in Q3/22, noted an Echelon Capital Markets report.
Tags:  Gold

Co. Among Top 10 Gold Producers Reports In Line Q3/22 Results

Research Report
  ()
The outlook for full-year 2022 production is positive, and growth is expected, noted a Haywood Securities report.
Tags:  Gold

Life Sciences Co. Exceeds Expectations in Q3/22

Research Report
  ()
During the quarter, the Canadian specialty biopharma performed well and maintained a healthy balance sheet, such that it raised revenue guidance for this year, noted a Research Capital Corp. report.
Tags:  Biotechnology / Pharmaceuticals

Mining Royalty Co. Posts Best Cash Margins to Date

Research Report
  ()
Also, operating cash flow was a beat during this strong quarter for the Quebec-based firm, noted a Haywood Securities report.
Tags:  GoldSilver

Q4/22 Catalysts Could Boost Undervalued Biopharma Stock

Research Report
  ()
The year's final quarter is significant for this U.S.-based firm given the trio of significant clinical achievements in its sight, noted a Laidlaw & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Real Estate REIT Shows Strengthening Fundamentals

Research Report
  ()
Growth of net operating income and of net asset value is expected from this investment vehicle in the near and longer term, noted an Echelon Capital Markets report.
Tags:  Special Situations

New Drill Results From Idaho Point to Gold Resource Growth

Research Report
  ()
The explorer's ongoing exploration results at this project continue to be encouraging ahead of a mineral resource update expected next year, noted a Haywood Securities report.
Tags:  Gold

Drilling Proves 'Connector Zone' Exists at Gold Asset

Research Report
  ()
The owner of this Quebec project will include these exploration results in the upcoming definitive feasibility study, noted a Laurentian Bank Securities report.
Tags:  Gold

Pharma Co. Won't See Bump in Sales From New COVID Drug

Research Report
  ()
The U.S. Food and Drug Administration Advisory Panel denied the approval of this therapeutic for patients hospitalized with severe SARS-CoV-2, yet it is still a Buy, noted a Research Capital Corp. report.
Tags:  Biotechnology / Pharmaceuticals

Canadian Base Metals Co. Gains Two New Assets

Research Report
  ()
The company takeover just closed, and consequently, an NI 43-101 report from the acquirer is expected soon, noted a Research Capital Corp. report.
Tags:  Base Metals

Target Price Raised on Counterdrone Tech Co.

Research Report
  ()
The Australian firm warrants this change given its recent track record in growing revenue, noted a Bell Potter report.
Tags:  Technology

New Drill Results Expand Deposit, Leading to Buy Rating

Research Report
  ()
These early results of 2022 drilling at this Golden Triangle property highlight the presence of high silver grades and potential for future resource growth, noted a Haywood Securities report.
Tags:  GoldSilver

Firm to Gain Mining Royalty on Project in Ecuador for $50M

Research Report
  ()
The acquisition is a 0.6% net smelter return royalty on production that is estimated to start at this copper-gold property in late 2029, noted a Haywood Securities report.
Tags:  GoldBase Metals

Copper Project Returns 'Very Good' Drill Results

Research Report
  ()
This data set "highlights the potential of the southern starter pit and its ability to provide higher grade material for longer in the early years of the mine," noted a Research Capital Corp. report.
Tags:  GoldBase Metals

Medical Device Co.'s Q2/22 Results Better Than Expected

Research Report
  ()
Along with improving its numbers during the quarter, this firm sold its first ultrasound ablation machines in North America, noted a Research Capital Corp. report.
Tags:  Medical Devices

Expert Investing Ideas

"We think TLG's sale of 'noncore' land for CA$40M is accretive."

–Brandon Gaspar, Sprott Equity Research


"MAG has been the best performing silver stock in the past weeks."

–Chen Lin, What Is Chen Buying? What Is Chen Selling?


"Today's TLG drill results confirm the new high-grade 'Connector zone.'"

–Jacques Wortman, Laurentian Bank Securities


"The results EMO published today help expand Romanera's footprint."

–Adam Schatzker, Research Capital Corporation


"LGD looks very cheap at these levels, all things considered."

–James Kwantes, Resource Opportunities


Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

With 14 Active Rigs, Co. Lines Up Another Deposit To Drill

Research Report
  ()
Given the amount of drilling happening at this Spanish project and the new drill data so far, it is likely the new resource estimate will exceed the historical one, noted a Research Capital Corp. report.
Tags:  GoldBase MetalsSilver

Analyst Says, 'Invest Now' in this Attractive Mining Co.

Research Report
  ()
This firm, with both high-grade silver and gold assets in one project, already has a resource large enough for a mining-processing operation, noted a Haywood Securities report.
Tags:  SilverGold

PFS on Rare Earth Co.'s B.C. Project Expected to be 'Robust'

Research Report
  ()
With this season's drilling behind it, the Canadian explorer plans to start, by year-end, the next step in advancing its project, noted a Noble Capital Markets report.
Tags:  Critical Metals

Biopharma Gains Two Cancer Cell Therapy Programs and a Target Price 10 Times Current

Research Report
  ()
This developer of cancer immunotherapies will take possession of these clinical-stage assets in a transaction with GSK and subsequently advance them toward approval, noted a ROTH Capital Partners report.
Tags:  Biotechnology / Pharmaceuticals

Potential ROI With German Biopharma Co. Notable

Research Report
  ()
This firm, with eight treatment candidates for mental health disorders in development, boasts a catalyst-rich next two months, noted a ROTH Capital Partners report.
Tags:  PsychedelicsBiotechnology / Pharmaceuticals

Biopharma Co. Shows Large Potential Return

Research Report
  ()
Palatin Technologies Inc.'s third-party clinical trial of Vyleesi in women with hypoactive sexual desire disorder was just published in the Journal of Clinical Investigation, and the biopharma offers investors significant potential return, noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Gold Mining Co. Makes 'Excellent' Discovery

Research Report
  ()
In addition to this news, the Canadian company is trading at a discount to peers, noted a Stifel report.
Tags:  GoldBase MetalsSilver

Steady News Stream Expected From Exploration Co.

Research Report
  ()
With 13 active drill rigs at its project in Spain, this Canadian mining firm should continue announcing results over the near term, noted a Research Capital Corp. report.
Tags:  GoldBase MetalsSilver

Analyst Calls Rare Earth Co.'s Property a 'Logistical Dream'

Research Report
  ()
This Canadian critical metals firm with many "attractive attributes" is well-positioned to become a globally significant rare earth oxide producer, noted an Agentis Capital report.
Tags:  Critical Metals